We are live on ! Find out more
AZN icon

AstraZeneca
AZN

331 hedge funds and large institutions have $5.84B invested in AstraZeneca in 2013 Q2 according to their latest regulatory filings, with 331 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

227% more call options, than puts

Call options by funds: $100M | Put options by funds: $30.6M

9.87% more ownership

Funds ownership: 0% → 9.87% (+9.9%)

Holders
331
Holders Change
+331
Holders Change %
–
% of All Funds
10.8%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.16%
New
331
Increased
–
Reduced
–
Closed
–
Calls
$100M
Puts
$30.6M
Net Calls
+$69.5M
Net Calls Change
+$69.5M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MWNA
101
Marshall Wace North America
New York
$3.96M +$4.27M +83,778 New
HVC
102
Healthcare Value Capital
New Jersey
$3.89M +$4.19M +82,239 New
FB
103
Fulton Bank
Pennsylvania
$3.85M +$4.14M +81,391 New
FAAM
104
First Allied Asset Management
California
$3.79M +$4.08M +80,029 New
Truist Financial
105
Truist Financial
North Carolina
$3.65M +$3.93M +77,143 New
MPM
106
Meritage Portfolio Management
Kansas
$3.43M +$3.69M +72,501 New
PRC
107
Platte River Capital
Colorado
$3.27M +$3.52M +69,190 New
BFA
108
BlackRock Fund Advisors
California
$3.17M +$3.41M +66,957 New
MAM
109
Martingale Asset Management
Massachusetts
$3.05M +$3.28M +64,452 New
BIT
110
BlackRock Institutional Trust
California
$3.01M +$3.24M +63,600 New
AllianceBernstein
111
AllianceBernstein
Tennessee
$2.97M +$3.2M +62,856 New
PNC Financial Services Group
112
PNC Financial Services Group
Pennsylvania
$2.97M +$3.19M +62,714 New
FAAS
113
First Allied Advisory Services
California
$2.89M +$3.11M +61,046 New
WT
114
Wilmington Trust
Delaware
$2.85M +$3.07M +60,215 New
SNC
115
Stifel Nicolaus & Co
Missouri
$2.72M +$2.92M +57,402 New
Fiera Capital (Canada)
116
Fiera Capital (Canada)
Quebec, Canada
$2.7M +$2.91M +57,100 New
FTI
117
Fiduciary Trust International
Massachusetts
$2.59M +$2.78M +54,690 New
KeyBank National Association
118
KeyBank National Association
Ohio
$2.58M +$2.78M +54,580 New
DCM
119
Dynamic Capital Management
Jersey
$2.57M +$2.77M +54,376 New
MA
120
MUFG Americas
New York
$2.55M +$2.74M +53,882 New
KCG
121
Knight Capital Group
$2.54M +$2.74M +53,779 New
BL
122
BCWM LLC
Kansas
$2.54M +$2.73M +53,675 New
Citigroup
123
Citigroup
New York
$2.5M +$2.69M +52,844 New
MCM
124
Matterhorn Capital Management
Texas
$2.46M +$2.65M +51,960 New
ZCM
125
Ziegler Capital Management
Illinois
$2.37M +$2.55M +50,000 New
3 4
5
6 7

AZN Hedge Fund Activity: Q2 2013 in Review

331 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZN) for Q2 2013, worth a combined $5.84B.

Buyers outnumbered sellers: 331 funds opened new AZN positions and 0 closed out — a net gain of 331 holders — while 0 added to existing stakes and 0 trimmed.

  • 331 institutional investors held AstraZeneca (AZN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $5.84B of AstraZeneca stock for Q2 2013.
  • 331 funds opened new AstraZeneca positions in Q2 2013 and 0 closed out, a net change of +331 holders.

Based on aggregated 13F filings for Q2 2013.